Atlas Trials

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Clinical trial NCT00384553 · UNKNOWN

Trial details

NCT number
NCT00384553
Sponsor
University of Magdeburg
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma
Start date
2004-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.